Central serous chorioretinopathy: An evidence-based treatment guideline

HMA Feenstra, EHC Van Dijk, CMG Cheung… - Progress in Retinal and …, 2024 - Elsevier
Central serous chorioretinopathy (CSC) is a relatively common disease that causes vision
loss due to macular subretinal fluid leakage and is often associated with reduced vision …

[HTML][HTML] Serous business: delineating the broad spectrum of diseases with subretinal fluid in the macula

EHC van Dijk, CJF Boon - Progress in retinal and eye research, 2021 - Elsevier
A wide range of ocular diseases can present with serous subretinal fluid in the macula and
therefore clinically mimic central serous chorioretinopathy (CSC). In this manuscript, we …

Adult-onset foveomacular vitelliform dystrophy: a fresh perspective

I Chowers, L Tiosano, I Audo, M Grunin… - Progress in retinal and …, 2015 - Elsevier
Adult-onset foveomacular vitelliform dystrophy (AFVD) was first described by Gass four
decades ago. AFVD is characterized by subretinal vitelliform macular lesions and is usually …

Optical coherence tomography reflective drusen substructures predict progression to geographic atrophy in age-related macular degeneration

M Veerappan, AKM El-Hage-Sleiman, V Tai, SJ Chiu… - Ophthalmology, 2016 - Elsevier
Purpose Structural and compositional heterogeneity within drusen comprising lipids,
carbohydrates, and proteins have been previously described. We sought to detect and …

Macular dystrophies mimicking age-related macular degeneration

NTM Saksens, M Fleckenstein… - Progress in retinal and …, 2014 - Elsevier
Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in
the elderly population in the Western world. AMD is a clinically heterogeneous disease …

Clinical characteristics, choroidal neovascularization, and predictors of visual outcomes in acquired vitelliform lesions

C Balaratnasingam, QV Hoang, M Inoue… - American journal of …, 2016 - Elsevier
Purpose To quantify the temporal properties of the acquired vitelliform lesion (AVL) life cycle,
define the clinical characteristics of choroidal neovascularization (NV) in this setting, and …

Correlation of type 1 neovascularization associated with acquired vitelliform lesion in the setting of age-related macular degeneration

CA Curcio, C Balaratnasingam, JD Messinger… - American Journal of …, 2015 - Elsevier
Purpose To correlate postmortem histology with previously recorded multimodal imaging
from a patient with type 1 neovascularization (NV) associated with an acquired vitelliform …

Risk Factors for Worsening Morphology and Visual Acuity in Eyes with Adult-Onset Foveomacular Vitelliform Dystrophy

GE Nipp, K Sarici, T Lee, M Hadziahmetovic - Ophthalmology Retina, 2024 - Elsevier
Purpose To explore clinical risk factors and OCT features associated with worse visual
acuity (VA), progression of disease, choroidal neovascularization (CNV), and atrophy in …

Incidence and risk factors for macular atrophy in acquired vitelliform lesions

S Chandra, S Gurudas, A Narayan, S Sivaprasad - Ophthalmology Retina, 2022 - Elsevier
Purpose To study the time course to macular atrophy (MA) and associated risk factors in
eyes with acquired vitelliform lesions (AVLs) as they vary between patients and between …

Ranibizumab for choroidal neovascularization associated with adult-onset foveomacular vitelliform dystrophy: one-year results

G Mimoun, V Caillaux, G Querques, PR Rothschild… - Retina, 2013 - journals.lww.com
Purpose: To evaluate the efficacy of intravitreal injections of ranibizumab for choroidal
neovascularization associated with adult-onset foveomacular vitelliform dystrophy. Methods …